- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02132585
Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular Dysfunction (SPEEDCARS)
May 5, 2014 updated by: Gianturco Luigi, University of Roma La Sapienza
Cross Sectional Study of Use of Speckle Tracking Echocardiography in the Early Diagnosis of Cardiovascular Dysfunction and Performance in Sjogren Patients
Speckle tracking (STE) is a novel echocardiographic technique which permits calculation of myocardial velocities and deformation parameters such as strain and strain rate (SR).
It is demonstrated that these parameters provide important insights into systolic and diastolic function, ischaemia, myocardial mechanics and many other pathophysiological processes of the heart.
In this preliminary study, we investigated the role of STE in detection of early ventricular dysfunction in patients with Sjogren Syndrome, focusing on cardiorespiratory fitness.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
700
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Milan, Italy
- Galeazzi IRCCS of Milan
-
Rome, Italy
- Sapienza University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Consecutive patients enrolled from cardiovascular clinic
Description
Inclusion Criteria:
- Diagnosis of Sjogren Syndrome
Exclusion Criteria:
- previous cardiovascular events
- unstable angina
- stroke
- diagnosis of heart failure
- incapacity to provide an informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Sjogren
Sjogren Patients evaluated with Speckle tracking echocardiography
|
|
Control
Controls Speckle tracking echocardiography
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Longitudinal Myocardial Strain reduction in Sjogren Patients
Time Frame: Baseline, 24 weeks
|
Longitudinal Myocardial Strain reduction could be an early marker of cardiac dysfunction in patients with Sjogren Syndrome, significantly better than common measurement (such as ejection fraction)
|
Baseline, 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Association between 6minute-walking-test and Longitudinal strain reduction
Time Frame: baseline, 24 weeks
|
Longitudinal strain reduction could be linked to decrease in cardiorespiratory fitness, especially in 6-minute-walking-test
|
baseline, 24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
March 1, 2013
Study Completion (Anticipated)
May 1, 2014
Study Registration Dates
First Submitted
May 5, 2014
First Submitted That Met QC Criteria
May 5, 2014
First Posted (Estimate)
May 7, 2014
Study Record Updates
Last Update Posted (Estimate)
May 7, 2014
Last Update Submitted That Met QC Criteria
May 5, 2014
Last Verified
February 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Immune System Diseases
- Autoimmune Diseases
- Eye Diseases
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Connective Tissue Diseases
- Arthritis
- Stomatognathic Diseases
- Mouth Diseases
- Lacrimal Apparatus Diseases
- Arthritis, Rheumatoid
- Xerostomia
- Salivary Gland Diseases
- Dry Eye Syndromes
- Sjogren's Syndrome
Other Study ID Numbers
- Spk-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sjogren Syndrome
-
Pontificia Universidad Catolica de ChileFormulario MAgistral Farmacias AhumadaCompletedXerostomia | Primary Sjogren | Secondary SjogrenChile
-
Federal University of São PauloAllerganCompletedEvaporative Dry Eye Disease | Primary Sjogren Syndrome | Secondary Sjogren Syndrome | Aqueous Deficient Dry Eye DiseaseBrazil
-
Novartis PharmaceuticalsRecruitingSjogren SyndromeUnited States, Belgium, Austria, Brazil, Mexico, Portugal, China, Turkey, Spain, Chile, Poland, Germany, Guatemala, Korea, Republic of, Czechia, France, Lithuania, Singapore
-
Novartis PharmaceuticalsTerminatedSjogren Syndrome | Mixed Connective Tissue DiseaseSpain, Hungary, Germany, China, Poland, Taiwan
-
University of NebraskaCompletedSjogren-Larsson Syndrome (SLS)United States
-
Federal University of São PauloCompletedXEROSTOMIA | KERATOCONJUNCTIVITIS SICCA | SICCA SYNDROME | PRIMARY SJOGREN SYNDROMEBrazil
-
Novartis PharmaceuticalsRecruitingSjogren SyndromeUnited States, China, Germany, Lebanon, India, Spain, Hungary, Brazil, Israel, Canada, Italy, Chile, Colombia, Argentina, Greece, United Kingdom, Taiwan, Australia, Bulgaria, Japan, Mexico, South Africa, France, Romania, Poland, Slovakia, S...
-
Novartis PharmaceuticalsActive, not recruiting
-
Novartis PharmaceuticalsCompletedPrimary Sjogren SyndromeUnited States, Belgium, Italy, Austria, Israel, France, Germany, Hungary, Netherlands, United Kingdom, Japan, Portugal, Argentina, Spain, Taiwan, Russian Federation, Romania, Chile, Poland
-
Meir Medical CenterUnknownPrimary Sjogren Syndrome With Multisystem Involvement
Clinical Trials on Speckle tracking echocardiography
-
Marco Stephan Lofrano AlvesUnknownDecompensated Heart FailureBrazil
-
Ahmed Mohamed Moheb El-DinNot yet recruitingPatent Ductus Arteriosus | Congenital Heart Defect
-
University Hospital, MontpellierCompletedMyocardial Function | Echographic Parameters Obtaind by Speckle Tracking | Chilhood CancersFrance
-
Assiut UniversityUnknown
-
Assiut UniversityUnknown
-
Assiut UniversityUnknownMyocardial Infarction | Left Ventricular Dysfunction | Echocardiography 2DEgypt
-
Aswan UniversityNot yet recruiting
-
Assiut UniversityNot yet recruiting
-
Peking University Third HospitalRecruitingPrognostic Value of Right Ventricular Myocardial Strain in Patients With Acute Myocardial InfarctionAcute Myocardial InfarctionChina
-
Haiyan WangActive, not recruitingCOVID-19 PandemicChina